Item 8.01. Other Events.
As previously announced, on March 24, 2022, Accelerate Diagnostics, Inc. (the
"Company") entered into a securities purchase agreement (the "Securities
Purchase Agreement") with the Jack W. Schuler Living Trust (the "Schuler Trust")
for the issuance and sale by the Company of an aggregate of an aggregate of
2,439,024 shares of the Company's common stock (the "Shares") to the Schuler
Trust in an offering (the "Private Placement") exempt from registration pursuant
to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506
promulgated thereunder. On December 16, 2022, the Company and the Schuler Trust
agreed to further extend the closing date of the Private Placement to March 31,
2023, subject to the satisfaction of customary closing conditions. All other
terms of the Securities Purchase Agreement remain unchanged.
© Edgar Online, source Glimpses
ACCELERATE DIAGNOSTICS, INC. 
